Company Profile

Company Description

ProMIS Neurosciences Inc. is a biotechnology firm focused on discovering and developing precision therapeutics for neurodegenerative diseases, particularly Alzheimer’s and ALS. The company utilizes its proprietary computational platform to identify novel targets and design antibody therapies that selectively bind to toxic misfolded proteins. Their research aims to slow or halt disease progression by targeting underlying pathological mechanisms. With a strong emphasis on scientific innovation, the firm collaborates with academic and industry partners to advance its pipeline of potential treatments. Their work holds promise for addressing unmet medical needs in neurodegenerative disorders.